Deadline: 11-Jul-23
The Global Health Innovative Technology Fund (GHIT Fund) is pleased to announce the Product Development Investment Opportunity for the development of new drugs, vaccines, or diagnostics for infectious diseases that are prevalent in the developing world.
The Global Health Innovative Technology Fund (GHIT Fund) is a non-profit organization focused on promoting the discovery and development of new health technologies, including drugs, vaccines, and diagnostics for infectious diseases prevalent in developing countries.
The GHIT Fund aims to advance Japan’s wealth of health technology innovation for the discovery and development of new technologies for developing world patients and populations affected by infectious disease. To this end, the GHIT Fund will catalyze R&D partnerships between Japanese and non-Japanese organizations and support these partnerships through GHIT Fund investments.
The GHIT Fund focuses on leveraging Japanese innovation and expertise to develop innovative drugs, vaccines, and diagnostics that are affordable and accessible to endemic populations.
The proposed collaboration projects should be no more than two years in duration and may focus on a broad array of R&D activities, including:
- Lead optimization
- Preclinical Development (in-vivo studies, formulation development, chemistry and process validation)
- Clinical Development (Phase 1, 2, or 3 studies, manufacturing scale-up)
- Activities to support licensure and WHO prequalification
Eligibility Criteria
- The GHIT Fund requires each investment to have at least one eligible Japanese and one eligible non-Japanese organization as partners in order to be considered eligible.
- Japanese Organizations
- Japanese corporations (with a research facility in Japan)
- Not-for-profit research organizations and foundations
- Government research institutions
- Academic institutions
- Non-Japanese Organizations
- Life Science/Healthcare companies
- Not-for-profit research organizations and foundations
- Product Development Partnerships
- Government research institutions
- Academic institutions
For more information, visit GHIT Fund.